Treelet Health Daily News - March 6, 2026
Top Story: AI Healthcare Enters Large-scale Implementation Phase
AI Becomes "Good Assistant" for Medical Staff
Recently, experts at Beijing Anzhen Hospital Tongzhou Campus used the "Tiange" orthopedic robot system for bone and joint surgery. In the intensive care unit of Peking University Shenzhen Hospital, doctors leveraged the Mindray Qiyuan large model to complete data backtracking and integration of the entire diagnosis and treatment process within 5 seconds, generating structured medical records in 1 minute, accelerating clinical treatment.
In Xi'an Northern Hospital, AI application can compress aortic dissection imaging diagnosis time from 15-20 minutes to 3 minutes, winning precious time for life-saving treatment. In lung nodule screening, AI helps radiologists reduce workload by 30% to 50%, improving overall hospital imaging diagnosis efficiency by 30% and shortening average patient waiting time by 42%.
Full-chain Application Scenario Expansion
Currently, global AI healthcare is in a growth phase of technological deepening and scenario differentiation, with modern medicine's AI applications entering the large-scale implementation stage. From a clinical practice perspective, AI healthcare application maturity shows a pattern of "diagnosis and treatment leading, prevention following, rehabilitation starting."
In terms of policy, in November 2024, the National Health Commission and other departments jointly issued the "Reference Guide for Artificial Intelligence Application Scenarios in the Health Industry," listing 84 typical application scenarios and clarifying AI's auxiliary position. This fills the gap in industry application standards and effectively avoids blind development and disorderly application.
AI Breaks Through Rare Disease Diagnosis and Treatment
Rapid Progress in Rare Disease Management
In 2025, empowered by AI, China's rare disease diagnosis and treatment achieved milestone breakthroughs. During the same period, 48 drugs were approved in China's rare disease field, covering over 20 rare diseases.
Rare disease large models such as Peking Union Medical College Hospital's "Xiehe·Taichu" and Tongji Hospital's "Nezha·Lingtong" have entered clinical application. The "DeepRare" traceable intelligent agent rare disease diagnosis system jointly developed by Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Shanghai Jiao Tong University was officially launched on July 26, 2025. In just six months, it has attracted over 1,000 professional users and covered more than 600 medical and research institutions worldwide, significantly shortening the identification cycle for difficult cases.
Listed Companies Racing in Rare Disease AI Track
- BGI Genomics: Independently developed the GeneT gene testing multimodal large model, which has completed clinical trials in multiple top-tier hospitals nationwide
- Dian Diagnostics: Successfully developed the first version of the Qidi Suowei multimodal biological data foundation model, adopting MoE architecture together with DeepSeek
- Saili Medical: Empowered by the domestic AI large model DeepSeek, reached strategic cooperation with Wuhan Jindou Medical to jointly build a rare disease diagnosis and treatment large model
2026 Global Health Trends
Three Emerging Health Trends
According to interviews with 58 experts by U.S. News & World Report, the three major health trends for 2026 are:
- Expanded Application of GLP-1 Drugs in Chronic Diseases (52%): These drugs will no longer be just "weight loss drugs" or "blood sugar control drugs," but will be more widely used for long-term management of various chronic diseases
- Diet Therapy/Dietary Intervention (38%): Using diet as an important tool for preventing and improving diseases, with specific nutritional plans to assist treatment
- Deep Integration of AI and Wearable Devices (38%): AI + smart devices can analyze health risks in real time, provide early warnings, and offer personalized health advice
Health Goals Recommended by Experts
Over half of experts (52%) chose "eat more beneficial foods," such as vegetables and whole grains. Experts generally believe that for ordinary people, eating more "good stuff" is easier to achieve than weight loss.
Effective Methods to Reduce Chronic Diseases
- Increase Fiber Intake (38%): Reduces colorectal cancer risk, promotes digestive health, and aids weight management
- Mediterranean Diet (69%): Consistently rated as the best diet by U.S. News & World Report, with significant benefits for cardiovascular health, metabolic function, and cognitive aging
Industry Data and Predictions
Rare Disease Market Size
- By 2028, the global rare disease market will reach $300 billion, accounting for 20% of the global prescription drug market
- China's rare disease drug market will grow from $1.3 billion in 2020 to $25.9 billion (approximately ¥180 billion) by 2030, with a compound annual growth rate of 34.5%
Digital Health Market
- By 2035, the digital health and wellness market will reach $2,352.67 billion
- Digital mental health applications supported over 970 million active users globally in 2023, an increase of 310 million users from 2020
Today's Health Tips
Expert Advice: In 2026, forget the simple "weight loss" goal and instead "eat more good things" - increase intake of vegetables, whole grains, and legumes. Particularly legumes, 50% of experts pointed out this is the most important practical advice for adopting a Mediterranean diet pattern.
Friendly Reminder: For those who prefer plant-based diets, experts recommend regular testing of key nutrients including vitamin B12, iron, omega-3 fatty acids, protein, calcium, zinc, and iodine to avoid illness due to nutrient deficiencies.
News Sources: CCTV.com, Sina Finance, Health Trend Reports, etc.
Treelet Health News System automatically generated on March 6, 2026